• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

颜色感觉的主要测试:临床方面。

Principal test for color sensation: clinical aspects.

机构信息

Public Interest Incorporated Foundation Isshinkai, 3-37-8 Hongo, Bunkyo-ku, Tokyo, 114-0033, Japan.

Nihon University, Tokyo, Japan.

出版信息

Jpn J Ophthalmol. 2024 Jul;68(4):259-292. doi: 10.1007/s10384-024-01075-1. Epub 2024 Jul 16.

DOI:10.1007/s10384-024-01075-1
PMID:39012573
Abstract

Visual function comprises three principles: light sensation, color sensation, and minimum separable sensation. Although clinical evaluation of light sensation and visual acuity have been remarkably developed through comprehensive application of various methods, the test methods to evaluate color sensation in the clinical field have not reflected these various significant developments after their recommendation at the International Congress of Ophthalmology in 1933. To date, various research methods in color vision have been invented on the basis of clinical evaluation methods, most of which were limited to laboratory investigations and were not applied to the clinical field. In this review, the author focuses on both the currently clinical available evaluation methods and the clinically applicable methods based on the present laboratory research studies.

摘要

视觉功能包含三个原则

光感、色觉和最小可分觉。虽然临床评估光感和视力已经通过各种方法的综合应用得到了显著发展,但在 1933 年国际眼科学会议推荐后,临床领域评估色觉的测试方法并没有反映出这些显著的发展。迄今为止,各种色觉研究方法都是在临床评估方法的基础上发明的,其中大部分仅限于实验室研究,并未应用于临床领域。在这篇综述中,作者重点介绍了目前临床可用的评估方法,以及基于目前实验室研究的临床适用方法。

相似文献

1
Principal test for color sensation: clinical aspects.颜色感觉的主要测试:临床方面。
Jpn J Ophthalmol. 2024 Jul;68(4):259-292. doi: 10.1007/s10384-024-01075-1. Epub 2024 Jul 16.
2
Colour vision testing in young children with reduced visual acuity.儿童低视力的色觉测试。
Acta Ophthalmol. 2020 Feb;98(1):e113-e120. doi: 10.1111/aos.14219. Epub 2019 Aug 30.
3
Level of visual acuity necessary to avoid false-positives on the HRR and Ishihara color vision tests.在HRR和石原色盲测试中避免假阳性所需的视力水平。
Eur J Ophthalmol. 2017 May 11;27(3):363-366. doi: 10.5301/ejo.5000855. Epub 2016 Sep 7.
4
The Change in Color Vision with Normal Aging Evaluated on Standard Pseudoisochromatic Plates Part-3.正常衰老过程中色觉变化的评估——标准假同色板第 3 部分。
Curr Eye Res. 2021 Jul;46(7):1038-1046. doi: 10.1080/02713683.2020.1843683. Epub 2020 Nov 15.
5
Spatial visual function in anomalous trichromats: Is less more?异常三色觉者的空间视觉功能:少即是多?
PLoS One. 2019 Jan 23;14(1):e0209662. doi: 10.1371/journal.pone.0209662. eCollection 2019.
6
Technical note: the effect of refractive blur on colour vision evaluated using the Cambridge Colour Test, the Ishihara Pseudoisochromatic Plates and the Farnsworth Munsell 100 Hue Test.技术说明:使用剑桥色觉测试、石原氏假同色图和法恩斯沃思-芒塞尔100色调测试评估屈光性模糊对色觉的影响。
Ophthalmic Physiol Opt. 2007 May;27(3):315-9. doi: 10.1111/j.1475-1313.2007.00469.x.
7
Impairment of acquired color vision in multiple sclerosis: an early diagnostic sign linked to the greatness of disease.多发性硬化症中获得性色觉障碍:一种与疾病严重程度相关的早期诊断体征。
Int Ophthalmol. 2019 Mar;39(3):671-676. doi: 10.1007/s10792-018-0838-x. Epub 2018 Feb 1.
8
[Evaluation of color perception in individuals addicted to narcotic substances in the Farnsworth-Munsell 100-Hue test].[在法恩斯沃思-芒塞尔100色调测试中对麻醉药品成瘾者颜色感知的评估]
Med Pr. 2016 Dec 22;67(6):777-785. doi: 10.13075/mp.5893.00469. Epub 2016 Dec 12.
9
Evaluation of a New Test for the Diagnosis of Congenital Dyschromatopsia in Children: the Color Vision Evaluation Test.先天性色觉异常诊断新试验评估:色觉评估试验。
Am J Ophthalmol. 2021 Mar;223:348-358. doi: 10.1016/j.ajo.2020.11.003. Epub 2020 Nov 19.
10
Evaluation of an updated HRR color vision test.一项更新的HRR色觉测试的评估。
Vis Neurosci. 2004 May-Jun;21(3):431-6. doi: 10.1017/s0952523804213463.

引用本文的文献

1
Comparison of Heidelberg Multi-Color Anomaloskop with NEITZ anomaloscope OT-II to diagnose color-vision deficiency.海德堡多色视标仪与NEITZ色盲检查镜OT-II诊断色觉缺陷的比较。
Jpn J Ophthalmol. 2025 Jul;69(4):549-557. doi: 10.1007/s10384-025-01198-z. Epub 2025 Apr 29.

本文引用的文献

1
A novel instrument to determine hue discrimination.一种用于确定色调辨别力的新型仪器。
Jpn J Ophthalmol. 2023 May;67(3):353-360. doi: 10.1007/s10384-023-00983-y. Epub 2023 Mar 24.
2
Variety of genotypes in males diagnosed as dichromatic on a conventional clinical anomaloscope.在传统临床色觉检查镜上被诊断为二色视者的男性中的多种基因型
Vis Neurosci. 2004 May-Jun;21(3):205-16. doi: 10.1017/s0952523804213293.
3
Tests for color deficiency based on the pseudoisochromatic principle; a comparative study of several new tests.
AMA Arch Ophthalmol. 1956 Feb;55(2):229-39. doi: 10.1001/archopht.1956.00930030233009.
4
The H-R-R polychromatic plates. II. Comparison of qualitative and quantitative classifications by H-R-R plates and other tests.
AMA Arch Ophthalmol. 1954 Sep;52(3):353-68.
5
The H-R-R polychromatic plates. I. A. test for the detection, classification, and estimation of the degree of defective color vision.
AMA Arch Ophthalmol. 1954 Feb;51(2):216-28.
6
Position of a 'green-red' hybrid gene in the visual pigment array determines colour-vision phenotype.“绿-红”杂交基因在视觉色素阵列中的位置决定了色觉表型。
Nat Genet. 1999 May;22(1):90-3. doi: 10.1038/8798.
7
[Studies on the printing color and the screening efficiency of the Ishihara test for color blindness. II. Evaluation of the screening efficiency of the Ishihara test published in 1979 and 1980 and the criterion of the detection].
Nippon Ganka Gakkai Zasshi. 1983;87(5):341-5.
8
[Color vision defect within normal Rayleigh match. (2) Pathophysiology].[正常瑞利匹配范围内的色觉缺陷。(2)病理生理学]
Nippon Ganka Gakkai Zasshi. 1984 Mar;88(3):516-22.
9
[Color vision defects in diabetic retinopathy (2). Correlation with clinical findings].糖尿病视网膜病变中的色觉缺陷(2)。与临床发现的相关性
Nippon Ganka Gakkai Zasshi. 1984 Feb;88(2):266-74.
10
[Ishihara-Okuma's new test-plates for colour-defectives (author's transl)].
Nippon Ganka Gakkai Zasshi. 1973 Sep;77(9):1359-65.